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Background: Possible immunization to blood group or other antigens and subsequent inhibition of remodeling or
incorporation after use of untreated human bone allograft was described previously. This study presents the
immunological, clinical and radiological results of 30 patients with acetabular revisions using fresh frozen
non-irradiated bone allograft.
Methods: AB0-incompatible (donor-recipient) bone transplantation was performed in 22 cases, Rh(D) incompatible
transplantation in 6 cases. The mean follow up of 23 months included measuring Harris hip score and radiological
examination with evaluation of remodeling of the bone graft, implant migration and heterotopic ossification. In
addition, all patients were screened for alloimmunization to Rh blood group antigens.
Results: Compared to the whole study group, there were no differences in clinical or radiological measurements
for the groups with AB0- or Rh(D)-incompatible bone transplantation. The mean Harris Hip Score was 80.6. X-rays
confirmed total remodeling of all allografts with no acetabular loosening. At follow up, blood tests revealed no
alloimmunization to Rh blood group donor antigens.
Conclusions: The use of fresh frozen non-irradiated bone allograft in acetabular revision is a reliable supplement to
reconstruction. The risk of alloimmunization to donor-blood group antigens after AB0- or Rh-incompatible allograft
transplantation with a negative long-term influence on bone-remodeling or the clinical outcome is negligible.
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Aseptic loosening is the most common long-term com-
plication in total hip arthroplasty. Revision of the failed
acetabular component remains challenging due to mi-
gration of the implant during loosening and procedures
to remove the primary implant often result in an exten-
sive loss of pelvic bone. Bone grafting combined with in-
sertion of a revision acetabular component is an
established method to restore pelvic bone stock [1-4].
Because of its limited availability and poor quality in eld-
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reproduction in any medium, provided the orfeasible. Therefore, allografts are utilized in most acetab-
ular revisions. Regardless of whether treated (chemical,
freeze dried, irradiated) or fresh-frozen non-irradiated
allografts are used, the clinical outcome is usually good
[5-7]. We have been using fresh frozen untreated allo-
grafts from our own bone bank in revision acetabular
hip arthroplasty for decades with good results. Neverthe-
less, immunization to blood group antigens or other
antigens and subsequent possible inhibition of long-term
remodeling or incorporation of the transplanted bone is
mentioned as an argument against the use of fresh fro-
zen non-irradiated allografts [8,9].
The purpose of this study was to evaluate whether
allografting of AB0- and Rh-incompatible patients
(donor-recipient) leads to recipient-alloimmunizationLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Mittag et al. BMC Musculoskeletal Disorders 2012, 13:187 Page 2 of 5
http://www.biomedcentral.com/1471-2474/13/187with proof of irregular erythrocyte antibodies (Rh sys-
tem). In addition, clinical and radiological findings
should be observed in the postoperative course.
Methods
Graft extraction
Femoral head bone grafts were obtained from donors
through total hip arthroplasty. The grafts were not trea-
ted, immediately double packed and stored at – 80°C at
our local bone bank. Besides blood group determination
(AB0 and Rhesus) donors were screened for infectious
diseases (HIV, Hepatitis B and -C, Syphilis) before and
at least six weeks after surgery according to the local
guidelines for operating a bone bank.
Patients
We retrospectively reviewed 30 patients (13 males, 17
females). The study was performed in compliance with
the Helsinki Declaration and approved by the local Eth-
ics Committee (Nr. 254/2010BO2, University Tuebingen,
Germany). Between 2006 and 2010 all included patients
received fresh frozen cancellous allograft bone from our
bone bank during acetabular revision at our institution
by the corresponding author (T.K.). Acetabular defects
were determined from preoperative radiographs and the
intraoperative assessment using the classification intro-
duced by Paprosky et al. [10]. Type I defects were
present in 8 hips (26.7%), type II A in 9 (30%), type II B
in 3 (10%), type II C in 3 (10%), type III A in 2 (6.7%),
type III B in 3 (10%) and type IV with complete pelvic
discontinuity in 2 (6.7%). The amount of impacted bone
material was determined by the size of the defect. AB0Table 1 Study groups
AB0-incompatible transplan
Number of patients (hips) 22
Gender (male:female) 8:14
Mean age in years (range) 71 (48 to 90)




Mean follow up in month (range) 21 (6 to 55)
Follow up
Alloantibodies to donor (Rh system**) none
Mean Harris Hip Score (range) 79.5 (53 to 100)
Acetabular component tilting in ° (range) 1.37 (0.1 to 3.3)
Horizontal migration in mm (range) 2.17 (0.1 to 6.0)
Vertical migration in mm (range) 1.27 (0 to 4.2)
Graft remodeling rate (%) 100
* Rh(D)-negative patients received bone from Rh(D)-positive donors.
** Screening for antibodies against 5 Rhesus antigens (D, C, c, E, e).incompatible (donor-recipient) bone transplantation was
performed in 22 cases. 6 Rh(D) negative patients
received bone from Rh(D) positive patients. In most
cases, revision components were implanted (Burch-
Schneider reinforcement ring or Mueller ring, Zimmer
GmbH, Switzerland) for acetabular reconstruction. The
average age at the time of surgery was 71 years (range
48 to 90).Follow up
All patients were screened for alloimmunization to Rh
blood group antigens (D, C, c, E, e) with a minimum
clinical and radiographic follow-up of 6 months (mean
23 months). We did not screen for further blood group
antigens.
Clinical assessments were evaluated according to the
criteria of the Harris Hip Score including scoring of
pain, walking and mobility of the revised hip [11].
Radiological evaluation was performed after 7 days,
6 weeks and at the time of study-related follow up at
least 6 months after surgery. The acetabular index and
horizontal and vertical migration of the acetabular com-
ponent were measured [12]. Acetabular component loos-
ening was defined if the sum of horizontal and vertical
migration was≥ 5 mm, if the change in the acetabular
index was ≥ 5° or if there was a progressive radiolucent
line ≥ 1 mm around the whole acetabular component
[13]. The Brooker-classification was used for determin-
ation of heterotopic ossification [14]. Remodeling of the
allograft was measured on the basis of appearance of tra-
becular remodeling within the graft.tation Rh(D)-incompatible transplantation* All patients
6 30
1:5 13:17




28 (14 to 38) 23 (6 to 63)
none none
86.3 (72 to 100) 80.6 (43 to 100)
1.00 (0.5 to 2.1) 1.29 (0 to 4,4)
2,27 (1.5 to 3.4) 2,01 (0.1 to 4.5)
1.13 (0 to 2.1) 1,44 (0 to 4.2)
100 100
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The paired t-test and Pearson´s chi square test were
used for intra-group analysis. The Pearson correlation
coefficient was calculated to measure the dependence




AB0 incompatible (donor-recipient) allograft transplant-
ation was performed in 22 cases, Rhesus(D)-incompatible
transplantation in 6 of 30 cases. No antibodies to donor
blood-antigens were found in any patient in the Rhesus-
system (Dd, Cc, Ee) during follow up. Especially Rh(D)
incompatible transplantation did not lead to a detect-
able alloimmunization. We also found no differences in
clinical or radiological measurements for these groups
(Table 1).
Clinical and radiological findings
The revision rate of the entire study group of 30 patients
was 3.3% due to a superficial septic complication in one
patient after an AB0- and Rh-compatible allograft trans-
plantation. All 30 acetabular components were still in
place at time of follow up. The mean Harris-Hip-Score
at the latest follow up was 80.6 points (range 43 to 100).
Significant acetabular component tilting > 5° (range 0° to
4.4°), horizontal migration ≥ 5 mm (0.1 to 6.0 mm) or
vertical migration ≥ 5 mm (0 to 4.2 mm) was found in
one case. All allografts remodeled with homogeneous
trabeculation and no radiolucent lines at the host-
allograft interface (Figure 1). Periacetabular heterotopic
ossification was found in 6 cases (20%): 5 patients with
grade II and 1 patient with grade III. However, in 5 of 6
cases, preoperative radiographs revealed heterotopic os-
sification of a similar grade. There was no correlationa b
Figure 1 a. Preoperative anteroposterior radiograph of a 72 year old
loosening of the acetabular component with migration into the smal
ring and fresh frozen non-irradiated allograft bone. Note the distinguishabl
cemented into the ring. c. 28-month follow up radiograph showing the im
bone and homogeneous trabeculation.between increasing preoperative acetabular defects and
Harris Hip Score at follow up (p = 0.46). Advanced age
was negatively correlated with the Harris Hip Score, but
did not reach statistical significance (R =−0.51, p = 0.21).
Discussion
The best method of preparation and processing of bone
allografts is still under discussion. We use fresh frozen
allografts in our department with no further chemical or
physical processing. The use of fresh frozen allografts
became subject to the restrictive European Union Dir-
ective due to the concern of a possible transmission of
an infectious disease or other illness [15]. A low risk of
disease transmission remains in some cases which are
described in the literature [16,17]. Sufficient donor-
screening is therefore essential. Except for Rh(D)-negative
females of childbearing age, fresh frozen allografts are
commonly transplanted AB0- and Rh-incompatible.
In the present study we found no alloimmunization in
Rh(D)-incompatible transplanted recipients. With respect
to other clinically relevant antigens in the Rh system (C, c,
E, e) no irregular antibodies could be detected in the reci-
pients after transplantation. However, reviewing the litera-
ture, there are some rare cases of Rh(D)-alloimmunisation
after bone grafting [18,19].
Concerning the AB0 system, the human body always
naturally contains antibodies against the other blood
group antigens (except genotype AB). Therefore, the de-
tection of anti-A or anti-B alloantibodies cannot be
regarded as proof of a possible alloimmunization after
AB0 incompatible transplantation. However, AB0 in-
compatible transplantation might cause an increase of
the anti-A or Anti-B titer (boostering) [20]. Due to the
retrospective design of our study, we could not investi-
gate a possible boostering of anti-A or Anti-B alloantibo-
dies after AB0-incompatible transplantation of bones.c
woman, 13 years after total hip replacement, showing aseptic
l pelvis (type III B). b. 7 days after acetabular revision using a Mueller
e allograft bone chips medial of the ring. A polyethylene cup was
plants to be unchanged with complete remodeling of the allograft
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before and after transplantation of frozen allogeneic
bone in orthopaedic or maxillo-facial surgery [21].
Despite the fact that we found no antibodies and
according to the current standards, we still recommend
transplanting only Rh(D)-negative bones to Rh(D)-negative
women of childbearing age. For all other patients, our
study confirms that blood-group compatible transplant-
ation of fresh frozen allografts is not necessary in revision
hip arthroplasty.
To minimize the risks of infection, allografts could be
sterilized by irradiation and chemical or physical treat-
ment. This treatment could result in a destruction of the
bone matrix and subsequent reduction in strength
affecting long-term graft incorporation [22]. Despite
this consideration, studies show good mid- and long-
term results of treated bone grafts in revision hip
arthroplasty [1-7,23-26].
Our study revealed 100% graft remodeling and only
one case of significant acetabular component migration
(6 mm migration with no clinical symptoms, no surgical
revision necessary) at a mean follow up of 23 months.
We found radiological evidence of good allograft trabe-
culation as a sign of complete remodeling and integra-
tion into the recipient bone structure, even after
6 months. This rapid remodeling rate has also been
demonstrated in several other studies [23,24]. We have
to consider, that complete remodeling does not mean
complete incorporation of the graft. This could only be
confirmed by biopsy and histological examination.
Acetabular reconstruction using a revision implant
and allograft bone for reconstructing pelvic bone stock
is a reliable method of managing acetabular defects. The
question remains whether to use treated or untreated
allografts in hip revision surgery as both show good
clinical results. Advantages of untreated fresh frozen
non-irradiated allografts are their cost effectiveness, sup-
posed better biological quality and availability in a local
bone bank. A disadvantage is the slightly increased risk of
disease transmission which can be minimized by sufficient
donor-screening and sterile handling.
Conclusions
We conclude that the risk of alloimmunization against
blood group antigens after AB0- or Rh-incompatible trans-
plantation of bone with an influence on bone-remodeling
or the clinical outcome is very low.
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